Cargando…
SARS-CoV-2 Nucleocapsid Protein Is a Potential Therapeutic Target for Anticoronavirus Drug Discovery
SARS-CoV-2, the etiologic agent of the COVID-19 pandemic, is a highly contagious positive-sense RNA virus. Its explosive community spread and the emergence of new mutant strains have created palpable anxiety even in vaccinated people. The lack of effective anticoronavirus therapeutics continues to b...
Autores principales: | Royster, Austin, Ren, Songyang, Ma, Yutian, Pintado, Melissa, Kahng, Eunice, Rowan, Sean, Mir, Sheema, Mir, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269701/ https://www.ncbi.nlm.nih.gov/pubmed/37199631 http://dx.doi.org/10.1128/spectrum.01186-23 |
Ejemplares similares
-
A novel compound targets the feline infectious peritonitis virus nucleocapsid protein and inhibits viral replication in cell culture
por: Mohseni, Nazleen, et al.
Publicado: (2023) -
A novel approach for the purification of aggregation prone proteins
por: Royster, Austin, et al.
Publicado: (2021) -
Hantaviruses use the endogenous host factor P58(IPK) to combat the PKR antiviral response
por: Wang, Zekun, et al.
Publicado: (2021) -
Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives
por: Dejani, Naiara Naiana, et al.
Publicado: (2021) -
Anticoronavirus Evaluation of Antimicrobial Diterpenoids: Application of New Ferruginol Analogues
por: Varbanov, Mihayl, et al.
Publicado: (2023)